Declining use of radiotherapy in stage i and II Hodgkin's disease and its effect on survival and secondary malignancies

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 619-625

  Koshy, Matthew ^a,b   Rich, Shayna E ^c   Mahmood, Usama ^c   Kwok, Young ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hodgkin's disease; Radiotherapy; Second malignancy

Indexed keywords

CONFIDENCE INTERVAL; HAZARD RATIO; HODGKIN'S DISEASE; KAPLAN-MEIER METHOD; MULTIVARIATE REGRESSION MODELS; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; REGRESSION MODEL; SECOND MALIGNANCY;

HAZARDS; PESTICIDE EFFECTS; RADIOTHERAPY; REGRESSION ANALYSIS;

DISEASES;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HAZARD RATIO; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SECOND CANCER; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; REGRESSION ANALYSIS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84855824764     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.069     Document Type: Article

References (27)

1. F.E. van Leeuwen, W.J. Klokman, and A. Hagenbeek Second cancer risk following Hodgkin's disease: A 20-year follow-up study J Clin Oncol 12 1994 312 325
2. M.A. Tucker, C.N. Coleman, and R.S. Cox Risk of second cancers after treatment for Hodgkin's disease N Engl J Med 318 1988 76 81
3. A.J. Swerdlow, A.J. Douglas, and G.V. Hudson Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation BMJ 304 1992 1137 1143
4. M. Henry-Amar Second cancer after the treatment for Hodgkin's disease: A report from the international database on Hodgkin's disease Ann Oncol 3 Suppl. 4 1992 117 128
5. J. Yahalom Role of radiation therapy in Hodgkin's lymphoma Cancer J 15 2009 155 160
6. E.M. Noordijk, J. Thomas, and C. Ferme First results of the EORTC-GELA H9 randomized trials: The H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin's lymphoma (HL) ASCO Meeting Abstracts 23 2005 6505 Available from: www.meeting.ascopubs.org/cgi/content/abstract/23/16-suppl/ 6505 Accessed Jan 28th, 2010
7. S. Laskar, T. Gupta, and S. Vimal Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: Is there a need? J Clin Oncol 22 2004 62 68
8. D.J. Straus, C.S. Portlock, and J. Qin Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease Blood 104 2004 3483 3489
9. R.M. Meyer, M.K. Gospodarowicz, and J.M. Connors Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group J Clin Oncol 23 2005 4634 4642
10. J.B. Nachman, R. Sposto, and P. Herzog Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy J Clin Oncol 20 2002 3765 3771
11. S. Pavlovsky, M. Maschio, and M.T. Santarelli Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease J Natl Cancer Inst 80 1988 1466 1473
12. J.G. Franklin, M.D. Paus, and A. Pluetschow Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk Cochrane Database Syst Rev 2005 CD003187
13. C. Herbst, F.A. Rehan, and C. Brillant Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: A systematic review Haematologica 95 2010 494 500
14. D.L. Longo Radiation therapy in the treatment of Hodgkin's disease - Do you see what I see? J Natl Cancer Inst 95 2003 928 929
15. T. Girinsky, and M. Ghalibafian Radiotherapy of Hodgkin lymphoma: Indications, new fields, and techniques Semin Radiat Oncol 17 2007 206 222
16. G.P. Canellos, J.C. Arseneau, and V.T. DeVita Second malignancies complicating Hodgkin's disease in remission Lancet 1 1975 947 949
17. L.S. Constine, N. Tarbell, and M.M. Hudson Subsequent malignancies in children treated for Hodgkin's disease: Associations with gender and radiation dose Int J Radiat Oncol Biol Phys 72 2008 24 33
18. A.J. Swerdlow, J.A. Barber, and A. Horwich Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital Br J Cancer 75 1997 116 123
19. S. Bhatia, L.L. Robison, and O. Oberlin Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 334 1996 745 751
20. E. Brusamolino, A.P. Anselmo, and C. Klersy The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher after combined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: A case-control study Haematologica 83 1998 812 823
21. J. Franklin, A. Pluetschow, and M. Paus Second malignancy risk associated with treatment of Hodgkin's lymphoma: Meta-analysis of the randomised trials Ann Oncol 17 2006 1749 1760
22. D.C. Hodgson, E.S. Gilbert, and G.M. Dores Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma J Clin Oncol 25 2007 1489 1497
23. P.M. Mauch, G.P. Canellos, and D.S. Rosenthal Reduction of fatal complications from combined modality therapy in Hodgkin's disease J Clin Oncol 3 1985 501 505
24. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors Blood 100 2002 1989 1996
25. W.J. Tester, T.J. Kinsella, and B. Waller Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute experience J Clin Oncol 2 1984 762 769
26. J.M. Kaldor, N.E. Day, and E.A. Clarke Leukemia following Hodgkin's disease N Engl J Med 322 1990 7 13
27. J.B. Yu, C.P. Gross, and L.D. Wilson NCI SEER public-use data: Applications and limitations in oncology research Oncology 23 2009 288 295